Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: A case report

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1375-1376

  Dammak, A ^a,b   Taille C ^a,b,c   Marinho, E ^b,d   Crestani, B ^a,b,c   Crickx, B ^a,b   Descamps, V ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

^d Service d'Anatomopathologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; HYALURONIC ACID; HYDROXYAPATITE; INTERFERON; OMALIZUMAB; PREDNISONE; STEROID;

ADULT; ALLERGIC ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; EYE SWELLING; FACE EDEMA; FEMALE; FOREIGN BODY GRANULOMA; HEPATITIS C; HUMAN; HUMAN TISSUE; LETTER; PRIORITY JOURNAL; SARCOIDOSIS; SKIN BIOPSY; TREATMENT DURATION;

ANTI-ASTHMATIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; ASTHMA; CHRONIC DISEASE; COSMETIC TECHNIQUES; DURAPATITE; FACIAL DERMATOSES; FEMALE; FOREIGN-BODY REACTION; HUMANS; HYALURONIC ACID; MIDDLE AGED; VISCOSUPPLEMENTS;

EID: 84861603701     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10817.x     Document Type: Letter

References (7)

1. Rivkin A,. New fillers under consideration: what is the future of injectable aesthetics? Facial Plast Surg 2009; 25: 120-3.
2. Requena L, Requena C, Christensen L, et al. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64: 1-34.
3. Descamps V, Landry J, Frances C, et al. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases. Dermatology 2008; 217: 81-4.
4. Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L,. Churg-Strauss syndrome in patients treated with omalizumab. Chest 2009; 136: 507-18.
5. Drobeck HP, Rothstein SS, Gumaer KI, et al. Histologic observation of soft tissue responses to implanted, multifaceted particles and discs of hydroxylapatite. J Oral Maxillofac Surg 1984; 42: 143-9.
6. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001; 108: 184-90.
7. Chipps B, Buhl R, Beeh K-M, et al. Improvement in quality of life with omalizumab in patients with severe allergic asthma. Curr Med Res Opin 2006; 22: 2201-8.